These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 30217944)
21. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway. Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750 [TBL] [Abstract][Full Text] [Related]
22. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs in cancer invasion and metastasis. Shen XH; Qi P; Du X Mod Pathol; 2015 Jan; 28(1):4-13. PubMed ID: 24925053 [TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer. Yang J; Wu W; Wu M; Ding J In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061 [TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin. Liu X; Tian X Med Sci Monit; 2021 Mar; 27():e929832. PubMed ID: 33716295 [TBL] [Abstract][Full Text] [Related]
26. lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4. Yu Y; He Y; Shao Y; Chen Q; Liu H Oncol Rep; 2020 Oct; 44(4):1511-1523. PubMed ID: 32945462 [TBL] [Abstract][Full Text] [Related]
27. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway. Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA LINC00511/miR-150/MMP13 axis promotes breast cancer proliferation, migration and invasion. Shi G; Cheng Y; Zhang Y; Guo R; Li S; Hong X Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):165957. PubMed ID: 33031905 [TBL] [Abstract][Full Text] [Related]
29. Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women. Xu N; Wang F; Lv M; Cheng L Biomed Pharmacother; 2015 Feb; 69():221-7. PubMed ID: 25661361 [TBL] [Abstract][Full Text] [Related]
30. MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer. Lai XN; Li J; Tang LB; Chen WT; Zhang L; Xiong LX Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054031 [TBL] [Abstract][Full Text] [Related]
31. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms. Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475 [TBL] [Abstract][Full Text] [Related]
32. A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer. Kong X; Li J; Li Y; Duan W; Qi Q; Wang T; Yang Q; Du L; Mao H; Wang C Cell Death Dis; 2021 Jul; 12(7):670. PubMed ID: 34218256 [TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980 [TBL] [Abstract][Full Text] [Related]
34. Newly identified lncRNA-45 promotes breast cancer metastasis through activating the mTOR signaling pathway. Qiu J; Guo Y; Wang S; Ren Q; Dong Z; Gao M; Ma J; Chen S; Liu S Biochem Biophys Res Commun; 2023 Jan; 640():40-49. PubMed ID: 36502630 [TBL] [Abstract][Full Text] [Related]
35. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation. Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623 [TBL] [Abstract][Full Text] [Related]
36. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Chen YM; Liu Y; Wei HY; Lv KZ; Fu P Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251 [TBL] [Abstract][Full Text] [Related]
37. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222 [TBL] [Abstract][Full Text] [Related]
38. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome. De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer. Sun G; Liu M; Han H J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707 [TBL] [Abstract][Full Text] [Related]
40. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer. Liang H; Zhao X; Wang C; Sun J; Chen Y; Wang G; Fang L; Yang R; Yu M; Gu Y; Shan H Mol Cancer; 2018 Jun; 17(1):96. PubMed ID: 29929545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]